Arvee Laboratories Intrinsic Value
Arvee Laboratories intrinsic value. Arvee Laboratories (ARVEE) median intrinsic value is ₹65.07 from 9 valuation models (range ₹43–₹108), vs current price ₹216.89 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. Compare with ARVEE fair price to assess whether the stock is under or overvalued.
ARVEE Valuation Methods Summary — DCF, Graham Number & P/E
Arvee Laboratories intrinsic value across 9 models vs current price ₹216.89 — upside/downside and value range per method. For current market price and key ratios, visit ARVEE share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹65.07 | ₹52.06 - ₹78.08 | -70.0% | EPS: ₹3.70, Sector P/E: 12x |
| Book Value Method | asset | ₹43.38 | ₹39.04 - ₹47.72 | -80.0% | Book Value/Share: ₹30.91, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹65.07 | ₹58.56 - ₹71.58 | -70.0% | Revenue/Share: ₹38.18, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹86.76 | ₹78.08 - ₹95.44 | -60.0% | EBITDA: ₹6.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹86.76 | ₹69.41 - ₹104.11 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹65.07 | ₹58.56 - ₹71.58 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹65.07 | ₹58.56 - ₹71.58 | -70.0% | Revenue Growth: -9.6%, Adj P/E: 8.0x |
| ROE Based Valuation | profitability | ₹108.44 | ₹97.60 - ₹119.28 | -50.0% | ROE: 11.8%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹65.07 | ₹58.56 - ₹71.58 | -70.0% | EPS: ₹3.70, BVPS: ₹30.91 |
ARVEE Intrinsic Value vs Market Price — All Valuation Models
Arvee Laboratories fair value range ₹43–₹108 vs current market price ₹216.89 across 9 valuation models. Read ARVEE dividend history for the complete payout history and dividend yield track record.
ARVEE Intrinsic Value Analysis — Undervalued or Overvalued?
Arvee Laboratories median intrinsic value ₹65.07, current price ₹216.89 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of ARVEE?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Arvee Laboratories (ARVEE) is ₹65.07 (median value). With the current market price of ₹216.89, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹43.38 to ₹108.44, indicating ₹43.38 - ₹108.44.
Is ARVEE undervalued or overvalued?
Based on our multi-method analysis, Arvee Laboratories (ARVEE) appears to be trading above calculated value by approximately 70.0%.
ARVEE Financial Health — Key Ratios vs Industry Benchmarks
Arvee Laboratories financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 12.50 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 11.8% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 11.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.98x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ARVEE Cash Flow Quality — Operating & Free Cash Flow
Arvee Laboratories operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2025 | ₹0 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹4 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹3 Cr | ₹3 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |